首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   40篇
  免费   1篇
  国内免费   1篇
妇产科学   1篇
基础医学   15篇
临床医学   5篇
内科学   6篇
外科学   1篇
综合类   3篇
预防医学   7篇
肿瘤学   4篇
  2022年   1篇
  2019年   1篇
  2014年   1篇
  2013年   1篇
  2012年   1篇
  2011年   2篇
  2010年   3篇
  2009年   1篇
  2008年   5篇
  2007年   5篇
  2006年   1篇
  2005年   2篇
  2004年   4篇
  2003年   3篇
  2002年   3篇
  2001年   3篇
  2000年   1篇
  1998年   2篇
  1996年   2篇
排序方式: 共有42条查询结果,搜索用时 15 毫秒
1.
应用NASBA定量检测HCV RNA的研究进展   总被引:6,自引:0,他引:6  
NASBA(nucleic acid sequence-based amplification)即核酸序列依赖性扩增法,是由一对引物介导的、连续均一的、体外特异性核苷酸序列等温扩增的RNA新技术。反应在42℃进行,可在2h内将RNA模板扩增约10^9倍。本文综述NASBA在HCV RNA定量检测中的应用。  相似文献   
2.
目的 评价实时荧光RT-PCR和核酸依赖性序列扩增法(NASBA)两种方法在呼吸道多病原检测中的应用价值。方法 收集北京地区急性呼吸道感染病例标本140份,分别采用实时荧光RT-PCR方法和NASBA方法对样本进行平行检测并对两种方法的病原检出限、重复性、检测一致性及检测时间等指标进行比较。结果 两种检测方法批内重复CV值均<5%,重复性较好;实时荧光RT-PCR方法对脊灰毒株核酸和H1N1病毒核酸最低检出限分别为5.62 CCID50 /0.1 ml(107 倍稀释)和103倍稀释度,NASBA方法最低检出限分别为56.2 CCID50 /0.1 ml(106 倍稀释)和102倍稀释。实时荧光RT-PCR灵敏度略优于NASBA方法。针对两种方法共同检测呼吸道病原体种类,实时荧光RT-PCR和NASBA方法检测阳性率分别为89.28%(125/140)、70%(98/140)。两种方法对甲型H1N1病毒、肠道病毒及新型冠状病毒的检测结果一致性达100%,对甲型流感病毒、甲型H3N2、副流感病毒1-4型的检测结果基本一致, Kappa 值范围为0.81~1;对冠状病毒229E/HKU1/OC43/NL63、鼻病毒、呼吸道合胞病毒和乙型流感病毒的检测结果一致性较好, Kappa 值范围为0.61~0.80;对人偏肺病毒的检测结果一致性差, Kappa 值仅为0.55。实时荧光RT-PCR方法检测时间为90 min,NASBA方法仅需40 min即可完成。 结论 实时荧光RT-PCR方法灵敏度较高,适合对大批量临床样本进行筛查;NASBA方法检测时间短,不易污染,适用于时限性强但对灵敏度要求不太高的应用场景,如临床上重症呼吸道感染者的快速检测。建议根据不同需求和应用场景,选择合适的检测方法和产品。  相似文献   
3.
国产实时荧光定量核酸检测试剂测定HIV病毒载量   总被引:1,自引:0,他引:1  
目的在目前进口试剂较昂贵的情况下,探讨国产实时荧光定量核酸检测试剂用于检测艾滋病病毒(HIV)病毒载量的可行性。方法2004年从全国4个省的HIV感染者/艾滋病(AIDS)患者采集110份样本,每份样本均同时使用生物梅里埃公司NASBA与深圳匹基生物公司实时荧光定量PCR两种方法测定血浆中HIV RNA含量,比较两种方法所得数据间的关系。结果HIV样本病毒载量处于3.5×103-1.0×105拷贝/ml范围时,一致性较好,存在一定线性关系;在小于103拷贝/ml范围内时,两种方法检测结果基本一致;当病毒载量处于1.0×103-3.5×103拷贝/ml范围时,两种方法检测结果偏差较大;病毒载量处于大于105拷贝/ml的范围时,虽然两种检测方法数值之间无相关性,但均显示处于105以上的较高数值范围。结论NASBA与实时荧光定量PCR两种检测方法在3.5×103-1.0×105拷贝/ml范围内有着高度的相关性,国产实时荧光定量核酸检测试剂检测结果与国际上较常用的病毒载量检测方法的结果之间的差异已经缩小,在低载量的检测敏感性还需要进一步优化。总体来说,使用国产实时荧光定量核酸检测试剂可以初略定量血浆中HIV RNA含量。  相似文献   
4.
Objective To evaluate the repeatability and reproducibility of four simplified molecular assays for the diagnosis of Trypanosoma brucei spp. or Leishmania ssp. in a multicentre ring trial with seven participating laboratories. Methods The tests are based on PCR or NASBA amplification of the parasites nucleic acids followed by rapid read‐out by oligochromatographic dipstick (PCR‐OC and NASBA‐OC). Results On purified nucleic acid specimens, the repeatability and reproducibility of the tests were Tryp‐PRC‐OC, 91.7% and 95.5%; TrypNASBA‐OC, 95.8% and 100%; Leish‐PCR‐OC, 95.9% and 98.1%; LeishNASBA‐OC, 92.3% and 98.2%. On blood specimens spiked with parasites, the repeatability and reproducibility of the tests were Tryp‐PRC‐OC, 78.4% and 86.6%; TrypNASBA‐OC, 81.5% and 89.0%; Leish‐PCR‐OC, 87.1% and 91.7%; LeishNASBA‐OC, 74.8% and 86.2%. Conclusion As repeatability and reproducibility of the tests were satisfactory, further phase II and III evaluations in clinical and population specimens from disease endemic countries are justified.  相似文献   
5.
The development and introduction of effective treatment for influenza A in the form of neuraminidase inhibitors have made the rapid diagnosis of infection important especially in high-risk populations. The aim of this study was to develop a real-time nucleic acid sequenced based amplification (NASBA) using a molecular beacon that could detect a wide range of influenza A subtypes and strains in a single reaction by targeting a conserved region of the influenza genome, and to evaluate its sensitivity and specificity against traditional laboratory techniques on a range of clinical samples usefulness during the 2003/2004 influenza season. The results demonstrated the assay to be highly sensitive and specific, detecting <0.1 TCID50 of virus stock. Three hundred eighty-nine clinical samples were tested in total from two patient groups. Overall, the real-time NASBA assay detected 64% (66/103) more influenza positive samples than cell culture and direct immunofluorescence (IF) and, therefore, was shown to be more sensitive in detecting influenza A in a wide range of respiratory samples than traditional methods. In conclusion, the real-time influenza A assay demonstrated clinical usefulness in both hospital and community populations.  相似文献   
6.
Probit regression analysis is frequently used to study the relation between the concentration of an analyte in a sample and the probability that the assay used yields a positive test result. For these analyses only the qualitative classification 'positive' or 'negative' is used, whereas, particularly in the case where the assay is quantitative in nature, the results contain more information. In the current paper, we propose an alternative method, in which the negative test results are treated as being (left) censored. As such, more efficient use is made of the information in the data. The procedures are illustrated using two generations of NucliSens assays (BioMérieux), which are designed to quantify the viral load of HIV-1 in blood samples. Computer simulations are used to illustrate some properties of the estimated parameters.  相似文献   
7.
Nucleic Acid Sequence Based Amplification (NASBA) is a suitable method for the quantification of HIV-1 RNA in plasma and serum samples. Since determination of the viral load appears to be a valuable marker for the prediction of disease progression and for monitoring the efficiency of antiretroviral therapy, the National AIDS Committee initiated the introduction of NASBA in Hungary at the end of 1996. We obtained plasma samples from patients with ARC and AIDS of the Szt. László Hospital, Budapest. We found an increased viral burden in untreated AIDS (CDC group C) patients compared to untreated ARC (CDC group B) patients. In plasma samples of clinically stable ARC and AIDS patients treated with antiretroviral drugs we detected relatively low HIV-1 RNA copy levels while similarly treated ARC and AIDS patients with progressive disease had high HIV-1 RNA copy numbers. The CD4+ T-cell count was lower in AIDS patients compared to ARC patients, as expected. In general, there was an inverse correlation (r = -0.487, P < 0.0001) between CD4+ T-cell counts and HIV-1 RNA levels. We concluded that measurement of HIV-1 RNA plasma level has an important role in assessing prognosis and effects of antiretroviral therapy in HIV-infected patients.  相似文献   
8.
目的: 基于核酸等温扩增技术(nucleic acid sequence-based amplification,NASBA)荧光分子信标探针检测技术,进行肠道病毒的快速检测与辅助诊断?方法:根据Genebank上肠道病毒5′端非编码区序列,设计特异性引物与捕获探针,应用纳米技术对商品化磁珠进行偶联,NASBA方法进行扩增,NucliSens读数仪检测,荧光定量RT-PCR方法进行验证,同时验证NASBA方法的特异性?灵敏度和重复性?结果:该方法对肠道病毒具有高度特异性,与RSV等呼吸道相关病毒均无交叉反应,反应体系具有很高的稳定性?结论:本研究应用的肠道病毒NASBA检测方法特异?灵敏?快速简便,适用于肠道病毒的日常监测和爆发疫情的应急诊断?  相似文献   
9.
10.
It has been suggested that human papillomavirus (HPV) testing improves follow-up of atypical cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) in cervical cancer screening programs. To evaluate the prognostic value of including HPV testing as an adjunct to cytology, we carried out a 2-year follow-up study of 77 women with ASCUS or LSIL Papanicolaou (Pap) smear in the Norwegian Cervical Cancer Screening Program (NCCSP) for detection of histological cervical intraepithelial neoplasia (CIN) 2+. The study includes a comparison between viral mRNA and DNA detection. PreTect HPV-Proofer was used for HPV E6/E7 mRNA detection from the 5 high-risk types 16, 18, 31, 33 and 45, and Gp5+/6+ consensus PCR was used for HPV DNA detection. Twice as many women were positive for HPV DNA (54.6%) than for HPV mRNA (23.4%). PreTect HPV-Proofer and consensus PCR had a sensitivity of 85.7% (95% confidence interval [CI] = 42.1-99.6) for detecting CIN2+ during follow-up. The specificity was significantly higher for PreTect HPV-Proofer, 84.9% (95% CI = 73.9-92.5), than for consensus PCR, 50.0% (95% CI = 37.4-62.6). PreTect HPV-Proofer positive women were 69.8 times (95% CI = 4.3-1137.3) more likely to be diagnosed with CIN2+ within 2 years than PreTect HPV-Proofer negative women. Consensus PCR-positive women were 5.7 times (95% CI = 0.6-52.0) more likely to be diagnosed with CIN2+ within 2 years than PCR-negative women. With equal sensitivity and higher specificity than consensus PCR, the PreTect HPV-Proofer might offer an improvement for the triage of women with ASCUS or LSIL Pap smear.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号